Skip to content
AwardedSpainGoods€371,883

Suministro del producto farmacéutico Cabozantinib para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria

Published
Published 9 July 2026

Overview

The Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria has awarded a contract for the supply of the pharmaceutical product Cabozantinib to Ipsen Pharma, S.A.U. on 10 June 2026 for 539,528.32 EUR. The procurement was for oncology medication to be provided to the hospital complex in Gran Canaria.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€371,883
Procedure
Direct
Published
9 July 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€539,528
Award date
10 June 2026
Winner
  • Ipsen Pharma, S.A.U.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 July 2026

Contracting authority

  • Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21063710150131

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro del producto farmacéutico Cabozantinib para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria — won by Ipsen Pharma, S.A.U. — Skim